JANUARY 31, 2019

Total revenue increased $7.3M to $488.2M and operating income increased $0.8M to $64.8M, up 1.5% and 1.2% when comparing 2018 to that of the prior year. These results are the most important indicators of our business. Fluctuations in our marketable securities continue to distort net income. Thus comparisons of net income to prior periods may no longer be meaningful.

The Board of Directors declared a reduced quarterly cash dividend of $0.56 per share on all of MEDITECH's outstanding common shares payable to holders of record at the close of business on January 28, 2019 with payment of such dividend to be made on Monday, February 11, 2019.

MEDITECH is pleased to provide access to its annual reports on Form 10-K and quarterly reports on Form 10-Q, just as soon as such reports are filed with the SEC. The reports listed below link to copies of the reports stored on MEDITECH's website.

FormDescriptionFiling Date
10-K2018 Annual Report2019 Jan 31
10-Q2018 3rd Quarter Report2018 Oct 31
10-Q2018 2nd Quarter Report2018 Jul 31
10-Q2018 1st Quarter Report2018 Apr 30
10-K2017 Annual Report2018 Jan 31
10-Q2017 3rd Quarter Report2017 Oct 31
10-Q2017 2nd Quarter Report2017 Jul 31
10-Q2017 1st Quarter Report2017 Apr 28
10-K2016 Annual Report2017 Jan 31
10-Q2016 3rd Quarter Report2016 Oct 31
10-Q2016 2nd Quarter Report2016 Jul 29
10-Q2016 1st Quarter Report2016 Apr 29
10-K2015 Annual Report2016 Jan 29
10-Q2015 3rd Quarter Report2015 Oct 30
10-Q2015 2nd Quarter Report2015 Jul 31
10-Q2015 1st Quarter Report2015 Apr 30

If you prefer to access all of the Company's filings on the SEC's website click here instead. To access our Code of Ethical Conduct click here. To access our By-Laws click here.